Ceylon Hospitals Plc

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: LK0338N00000
LKR
273.75
2.5 (0.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ceylon Hospitals Plc stock-summary
stock-summary
Ceylon Hospitals Plc
Hospital
Ceylon Hospitals PLC is a holding company. The Company's Durdans cardiac center offers Cardiac Surgical Intensive Care Unit (CSICU) with over 10 beds, including facilities for pediatric cardiac surgical procedures, Heart Command Center, cardiac catheterization laboratory and a Heart Station. The Company's subsidiaries include Ceylon Hospitals PLC, which is engaged in providing healthcare services; Durdans Heart Surgical Centre (Pvt) Ltd., which is engaged in providing cardiac surgical operations and interventional procedures; Durdans Medical and Surgical Hospital (Pvt) Ltd., which is engaged in providing healthcare services, and Ceygen Biotech (Pvt) Ltd., which is engaged in supplying of molecular biological, biochemical, biotechnological reagents, kits, equipment and accessories for molecular diagnostics and research purpose.
Company Coordinates stock-summary
Company Details
No.03, Alfred Place, Colombo 03 , COLOMBO None : 03
stock-summary
Tel: 94 11 5410000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ajith Tudawe
Executive Chairman of the Board, President
Upul Tudawe
Executive Vice President, Executive Director
Sathis Tudawe
Senior Vice President - Administration, Non-Executive Director, Chairman - Technical and Maintenance Subcommittee
Dr. A. Wijegoonewardene
Senior Vice President - Medical, Non-Executive Director
Mr. Aminda Tudawe
Non-Independent Executive Director
Mr. Asoka Abeyewardene
Independent Non-Executive Director
Mr. Ahangama Vithanage De Silva Jayatilleke
Non-Executive Independent Director
Mr. Ahamed Ismail
Non-Executive Independent Director
Y. Piyasena
Independent Non-Executive Director
Mr. Asite Talwatte
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2,537 Million
(Quarterly Results - Mar 2025)
Net Profit:
188 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

LKR Million (Small Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.02

stock-summary
Return on Equity

10.52%

stock-summary
Price to Book

0.00